(Press-News.org) Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), represent the most common chronic liver diseases in Western populations, driven largely by obesity and insulin resistance. MASH can progress to cirrhosis and hepatocellular carcinoma (HCC), with the incidence of MASH-related HCC rising rapidly. While lifestyle modification remains foundational, pharmacological intervention is increasingly important. This review explores the emerging role of nutrient-stimulated hormone-based therapies (NuSHs)—primarily glucagon-like peptide-1 receptor agonists (GLP-1RAs) and newer dual/triple incretin agonists—in the management of MASH and the potential prevention and adjunct treatment of MASH-associated HCC.
Established Beneficial Effects of NuSHs in MASH:
Clinical trials robustly support the efficacy of GLP-1RAs, such as semaglutide, in resolving MASH without worsening fibrosis, particularly in non-cirrhotic patients. Semaglutide demonstrated MASH resolution in 59–62.9% of patients in phase II/III trials, though fibrosis improvement in cirrhotic patients remains limited. Newer dual agonists (e.g., tirzepatide, survodutide) and triple agonists (e.g., retatrutide) show promising histological improvements, including significant reductions in liver fat and fibrosis markers. However, long-term data on hard clinical outcomes—such as progression to cirrhosis, HCC, or mortality—are still lacking.
Future Directions: A Role for NuSHs in MASH-HCC:
Preclinical and observational evidence suggests NuSHs may reduce HCC incidence and tumor burden, likely through systemic metabolic improvement rather than direct antitumor action. In murine models, semaglutide reduced HCC incidence by nearly half. Bariatric surgery data further underscore the preventive role of sustained weight loss. The proposed mechanisms include amelioration of insulin resistance, reduction of chronic inflammation and oxidative stress, and modulation of immune-metabolic pathways that drive hepatocarcinogenesis. NuSHs may also improve the hepatic microenvironment, potentially enhancing response to immunotherapies.
Proposed Immunotherapy Synergy as a Mechanism of Action:
In MASH-HCC, chronic inflammation and lipotoxicity create an immunosuppressive tumor microenvironment that can limit the efficacy of immune checkpoint inhibitors. By improving metabolic parameters and reducing hepatic inflammation, NuSHs may help “recondition” the liver, making it more receptive to immunotherapy. Additionally, improving overall metabolic health may enhance patient eligibility for liver transplantation and tolerance to systemic anticancer therapies.
Safety Considerations:
NuSHs are generally well-tolerated but carry notable side effects. Gastrointestinal symptoms (nausea, diarrhea) are common, especially with dual/triple agonists. Concerns about medullary thyroid cancer risk with GLP-1RAs remain unresolved, warranting caution in at-risk individuals. Sarcopenia is another important consideration, particularly in older or frail patients, though the ratio of fat-to-lean mass loss resembles that seen with lifestyle intervention. High-protein diets and resistance exercise are recommended to mitigate muscle loss.
Conclusion:
NuSHs, particularly GLP-1RAs, represent a promising therapeutic strategy not only for treating MASH but also for preventing MASH-related HCC. Their ability to modify key metabolic and inflammatory drivers of hepatocarcinogenesis supports their potential role in early intervention and as adjuncts to existing oncological therapies. Future research must focus on prospective trials with oncological endpoints, clarification of immunometabolic mechanisms, and evaluation of long-term safety and cost-effectiveness in integrated MASLD-HCC care pathways.
Full text
https://www.xiahepublishing.com/2310-8819/JCTH-2025-00303
The study was recently published in the Journal of Clinical and Translational Hepatology.
The Journal of Clinical and Translational Hepatology (JCTH) is owned by the Second Affiliated Hospital of Chongqing Medical University and published by XIA & HE Publishing Inc. JCTH publishes high quality, peer reviewed studies in the translational and clinical human health sciences of liver diseases. JCTH has established high standards for publication of original research, which are characterized by a study’s novelty, quality, and ethical conduct in the scientific process as well as in the communication of the research findings. Each issue includes articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of JCTH also include editorials, correspondences and invited commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and unsolicited, must pass our rigorous peer review process.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
Most research on the health effects of stress focuses on adults, but a new review looks at how stress uniquely affects children.
In the most comprehensive review of its kind to date, UC San Francisco researchers found robust evidence that stress occurring as early as before birth or as late as adolescence can affect multiple conditions in kids, from asthma to mental health to cognitive functioning. The results appear Jan. 20 in the Annual Review of Psychology.
Among the most important findings:
Stress can impact many areas at once — mental ...
Flue gas is exhausted from home furnaces, fireplaces and even industrial plants, and it carries polluting carbon dioxide (CO2) into the atmosphere. To help mitigate these emissions, researchers reporting in ACS Energy Letters have designed a specialized electrode that captures airborne CO2 and directly converts it into a useful chemical material called formic acid. The system performed better than existing electrodes in tests with simulated flue gas and at ambient CO2 concentrations.
“This work shows that carbon capture and conversion do not need to be treated as separate steps. By integrating both ...
The Department of Energy’s Oak Ridge National Laboratory (ORNL), Type One Energy and the University of Tennessee, Knoxville (UT), are partnering to establish a world-class facility that will drive American innovation and move fusion energy closer to reality.
This high-heat flux (HHF) facility, located at the Tennessee Valley Authority’s (TVA) Bull Run Energy Complex in East Tennessee, will evaluate how materials react under extreme conditions in a fusion device. The HHF facility will accelerate the development of plasma-facing components (PFCs), ...
New York, NY | January 21, 2026: The CUNY Graduate School of Public Health and Health Policy (CUNY SPH) is pleased to announce the launch of AI, Health, and Digital Spaces, a new section of the peer-reviewed Journal of Health Communication, International Perspectives. The section responds to the growing influence of artificial intelligence (AI) and digital platforms on how health information is created, shared, and understood, and marks an important step forward in advancing scholarship at the intersection of technology and public health communication.
The ...
Ammonia is an essential chemical used across many industries worldwide. Beyond its traditional role as a fertilizer, it is also a promising liquid hydrogen carrier and low-carbon fuel that could help reduce reliance on fossil fuels. However, conventional ammonia production based on the Haber–Bosch (HB) process requires considerable energy and contributes significantly to greenhouse gas emissions, accounting for roughly 1–1.3% of global emissions annually. Given its growing importance, there is an urgent need to reduce the environmental burden of ammonia production.
Recently, ...
Physical rehabilitation and symptom management still remain the mainstay of treatment for stroke, as clot removal or dissolution is effective only within a narrow time frame after the stroke. After that, many patients are left with long-term problems like difficulty in walking, speaking, and memory decline. Exercise has been beneficial in preventing strokes and improving recovery. However, the majority of these patients, being elderly, are too frail to exercise enough to gain these benefits.
In an ...
Thermal management is essential for reducing future heating and cooling energy consumption. Notably, the near-infrared (NIR) component of sunlight is closely associated with heat absorption. Hexagonal tungsten oxide nanorods are promising NIR-blocking electrochromic materials that change their color, transparency, and opacity upon the application of a small electric voltage. Their hexagonal tunnels, known as optically active sites, can effectively accommodate electrolyte ions and enable dynamic NIR ...
The language used to describe conflicts naturally reflects assumptions about how different forms of violence emerge and develop. “For instance, we think that 'civil wars' are the result of internal strife, and we debate whether wars should be characterized as matters of 'invasion' or 'defense.' In a similar way, experts also label conflicts to indicate important properties and to make patterns across conflicts comparable for use in systematic analysis, early warning, and ...
Highlights:
According to the American Heart Association’s 2026 Heart Disease and Stroke Statistics Update, heart disease remains the leading cause of death in the U.S. and stroke has moved up to the #4 spot.
Together, heart disease and stroke accounted for more than a quarter of all deaths in the U.S. in 2023, the most recent year for which data is available.
Cardiovascular diseases, including all types of heart disease and stroke, claim more lives in the U.S. each year than all forms of cancer and accidental deaths — the #2 and #3 causes of death — combined.
Embargoed until 4 a.m. CT / 5 a.m. ET Wednesday, Jan. 21, 2026
DALLAS, ...
A nanostructure made of silver and an atomically thin semiconductor layer can be turned into an ultrafast switching mirror device that may function as an optical transistor – with a switching speed around 10,000 times faster than an electronic transistor. An international team of researchers led by University of Oldenburg physicist Professor Dr. Christoph Lienau describes this effect in a paper published in the current issue of Nature Nanotechnology. Ultrafast light switches offer interesting prospects for optical data processing, the researchers explain.
The team’s goal was to find a material ...
